FutureChem Co.,Ltd (KOSDAQ:220100)
 19,310
 +740 (3.98%)
  Oct 31, 2025, 1:40 PM KST
FutureChem Co.,Ltd Revenue
FutureChem Co.,Ltd had revenue of 3.64B KRW in the quarter ending June 30, 2025, with 6.02% growth. This brings the company's revenue in the last twelve months to 19.14B, up 28.30% year-over-year. In the year 2024, FutureChem Co.,Ltd had annual revenue of 17.29B with 23.81% growth.
Revenue (ttm) 
 19.14B
Revenue Growth 
 +28.30%
P/S Ratio 
 21.44
Revenue / Employee 
 285.69M
Employees 
 67
Market Cap 
410.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 17.29B | 3.33B | 23.81% | 
| Dec 31, 2023 | 13.97B | 1.39B | 11.09% | 
| Dec 31, 2022 | 12.57B | 755.26M | 6.39% | 
| Dec 31, 2021 | 11.82B | 805.07M | 7.31% | 
| Dec 31, 2020 | 11.01B | 2.85B | 34.86% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Biologics | 5.03T | 
| Celltrion | 3.75T | 
| Yuhan | 2.17T | 
| SK Biopharmaceuticals | 620.28B | 
| PharmaResearch | 449.81B | 
| Sam Chun Dang Pharm. | 215.10B | 
| ALTEOGEN | 158.06B | 
| LigaChem Biosciences | 148.28B |